PHARMACOKINETIC OVERVIEW OF DOXAZOSIN

被引:55
作者
ELLIOTT, HL
MEREDITH, PA
REID, JL
机构
关键词
D O I
10.1016/0002-9149(87)90162-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:G78 / G81
页数:4
相关论文
共 11 条
[1]  
BAILEY RR, 1985, NEW ZEAL MED J, V98, P248
[2]   A PHARMACODYNAMIC AND PHARMACOKINETIC ASSESSMENT OF A NEW ALPHA-ADRENOCEPTOR ANTAGONIST, DOXAZOSIN (UK33274) IN NORMOTENSIVE SUBJECTS [J].
ELLIOTT, HL ;
MEREDITH, PA ;
SUMNER, DJ ;
MCLEAN, K ;
REID, JL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (05) :699-703
[3]  
FAULKNER JK, IN PRESS EUR J CLIN
[4]   A LONG-TERM DOUBLE-BLIND COMPARISON OF DOXAZOSIN AND ATENOLOL IN PATIENTS WITH MILD TO MODERATE ESSENTIAL-HYPERTENSION [J].
FRICK, MH ;
HALTTUNEN, P ;
HIMANEN, P ;
HUTTUNEN, M ;
PORSTI, P ;
PITKAJARVI, T ;
POYHONEN, L ;
PYYKONEN, ML ;
REINIKAINEN, P ;
SALMELA, P ;
SARASTE, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 :S55-S62
[5]   THE METABOLISM AND KINETICS OF DOXAZOSIN IN MAN, MOUSE, RAT AND DOG [J].
KAYE, B ;
CUSSANS, NJ ;
FAULKNER, JK ;
STOPHER, DA ;
REID, JL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 :S19-S25
[6]   APPLICATION OF PHARMACOKINETIC-PHARMACODYNAMIC MODELING FOR THE COMPARISON OF QUINAZOLINE ALPHA-ADRENOCEPTOR AGONISTS IN NORMOTENSIVE VOLUNTEERS [J].
MEREDITH, PA ;
ELLIOTT, HL ;
KELMAN, AW ;
REID, JL .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (03) :532-537
[7]   DETERMINATION OF THE VASODILATOR UK33274 BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY USING FLUORESCENCE DETECTION [J].
RUBIN, PC ;
BRUNTON, J ;
MEREDITH, P .
JOURNAL OF CHROMATOGRAPHY, 1980, 221 (01) :193-195
[8]  
SCOTT PJW, UNPUB DOUBLE BLIND C
[9]   POSTJUNCTIONAL SELECTIVITY OF ALPHA-BLOCKADE WITH PRAZOSIN, TRIMAZOSIN, AND UK-33,274 IN MAN [J].
SINGLETON, W ;
SAXTON, CAPD ;
HERNANDEZ, J ;
PRICHARD, BNC .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 :S145-S151
[10]   DOXAZOSIN, AN ALPHA-1-ADRENOCEPTOR ANTAGONIST - PHARMACOKINETICS AND CONCENTRATION-EFFECT RELATIONSHIPS IN MAN [J].
VINCENT, J ;
ELLIOTT, HL ;
MEREDITH, PA ;
REID, JL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (06) :719-725